絞り込み

17443

広告

A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.

著者 Chouinard G , Annable L , Turnier L , Holobow N , Szkrumelak N
Can J Psychiatry.1993 Nov ; 38 Suppl 4():S114-21.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Psychiatric Research Centre, Louis-H. Lafontaine Hospital, Montreal, Quebec.

スターを付ける スターを付ける     (2view , 0users)

Medical

This double-blind clinical trial studied 16 acutely agitated psychotic patients with manic or manic-like symptoms who needed rapid tranquilization and were therefore on maintenance treatment. They were randomized to receive intramuscular preparations of clonazepam (1 to 2 mg) or haloperidol (5 to 10 mg) at 0, 0.5, and 1.0 hours. Both medications produced significant reduction of manic symptoms within two hours of initial treatment; however, haloperidol produced beneficial results more rapidly than clonazepam. All patients completed the study, with the exception of one haloperidol-treated patient who developed severe parkinsonism. It was concluded that I.M. clonazepam is an effective, safe, but slower-acting alternative to I.M. haloperidol in the treatment of agitated psychiatric patients in need of rapid tranquilization.
PMID: 8306241 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード